Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
16–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Age 16 or over.
Have documentation of physician-confirmed diagnosis of moderate or severe Hemophilia A (severity defined as moderate = FVIII activity 1% to 5% and severe = FVIII activity ≤1%).
Signed written informed consent provided by the patient or the patient's parents for patients under the age of 18 (dependent of local regulations).
Signed written assent is also required for patients under the age 18 years (dependent on local regulations).
Plan to receive at least half of their Hemophilia care at the registry site.
Willing and able to enter data as per the data collection schedule.
Currently receiving prophylactic or on demand treatment (including within last 6months for on demand).
Expected life expectancy of at least 2 years.
You may not be if
Patients with Hemophilia B
Patients with von Willebrand disease (vWD)
Patients with other rare bleeding disorders
Unable to comply with the study protocol
Clareo Health | Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
